Horizon Therapeutics PLC (NASDAQ:HZNP)
| 88.65 Delayed Data As of 3:59pm ET |  +2.48 / +2.88%Today’s Change | 23.81 Today|||52-Week Range 96.54 | +21.19% Year-to-Date |
Latest HZNP News | Press Releases
| Horizon's (HZNP) Shares Rise on Q4 Earnings & Sales Beat Feb 25 / Zacks.com - Paid Partner Content | Horizon Therapeutics PLC (HZNP) Q4 2020 Earnings Call Transcript Feb 24 / MotleyFool.com - Paid Partner Content |
| Company News for Feb 25, 2021 Feb 25 / Zacks.com - Paid Partner Content | Halozyme (HALO) Q4 Earnings Miss, 2021 View Weak, Stock Falls Feb 24 / Zacks.com - Paid Partner Content |
| Why Horizon Therapeutics Stock Jumped Today Feb 24 / MotleyFool.com - Paid Partner Content | Horizon Therapeutics (HZNP) Q4 Earnings and Revenues Surpass Estimates Feb 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 86.17 |
| Today’s open | 87.38 |
| Day’s range | 81.43 - 89.41 |
| Volume | 87,381 |
| Average volume (3 months) | 2,496,393 |
| Market cap | $20.3B |
Data as of 3:59pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | -38.99% |
| Earnings growth (this year) | -1.20% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +69.26% |
| P/E ratio | 49.0 |
| Price/Sales | 7.16 |
| Price/Book | 5.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +1.54 | +1.49% |
| INCYIncyte Corp | +2.77 | +3.57% |
| VTRSViatris Inc | +0.34 | +2.50% |
| ALNYAlnylam Pharmaceutic... | +6.21 | +4.53% |
Data as of 4:00pm ET, 03/05/2021
Financials
| Next reporting date | May 12, 2021 |
| EPS forecast (this quarter) | $0.27 |
| Annual revenue (last year) | $2.2B |
| Annual profit (last year) | $389.8M |
| Net profit margin | 17.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
